Loading live market data…

Darling Ingredients Inc.

NYSE:DAR

$61.83 USD

-$0.2 (-0.32%)

Volume
1.54M
Average Volume
2.52M
Market Capitalization
$9.83B
P/E Ratio
43.85
Dividend Yield
0.00%
Price Target
$64.00
Year High
$66.02
Year Low
$29.15
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.58
Source Headline
Why Darling (DAR) Could Beat Earnings Estimates Again

Darling (DAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

zacks.com - 2026-07-14 13:10:33

Darling Ingredients Inc. to Release Second Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) announced today that it will host a conference call on Thursday, July 30, 2026, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss second quarter 2026 financial results, which will be released earlier that day, and provide an update on company operations. A presentation with accompanying supplemental financial data will also be available at darlingii.com/investors. To access the call as a listener, please register for the.

businesswire.com - 2026-07-09 16:30:00

Do Options Traders Know Something About Darling Ingredients Stock We Don't?

Investors need to pay close attention to DAR stock based on the movements in the options market lately.

zacks.com - 2026-07-02 13:30:41

4 Value Stocks to Buy Amid Costly AI Bets and Inflation

DAR, GPRE, TX and NEXA screen as high-earnings-yield value picks as inflation worries and AI spending fears sharpen stock selection.

zacks.com - 2026-06-26 09:26:04

4 Stocks to Buy as Online Grocery Sales Surge Amid Inflationary Woes

Online grocery sales jumped 19% in Q1 2026, putting TSN, CHEF, DAR and MAMA in focus amid rising grocery spending and high inflation.

zacks.com - 2026-06-25 09:51:11

Darling Ingredients' Health Brand Rousselot Receives U.S. Patent for Nextida® GC, the First Collagen Peptide Composition Supporting Blood Glucose Regulation

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) and its health brand Rousselot today announced that the U.S. Patent and Trademark Office (USPTO) has granted Patent No. US12636339 for Nextida GC, a first-of-its-kind collagen peptide ingredient developed to help support healthy after-meal blood sugar levels, naturally. The patent protects both the production process and the use of Nextida GC as a dietary supplement ingredient, offering a non-pharmaceutical option for managing.

businesswire.com - 2026-06-03 17:10:00

Nevada’s Only Refinery Just Got a Jet-Fuel Makeover Plan

WOODS CROSS, Utah, June 02, 2026 (GLOBE NEWSWIRE) -- Energy Metal News News Commentary - The U. S. refining map is getting smaller. West Coast capacity has been shrinking as older plants close, the major refiners spent the first quarter of 2026 emphasizing discipline over expansion, and the Trump administration has used Defense Production Act determinations to flag domestic refining as a strategic priority.

globenewswire.com - 2026-06-02 08:45:00

Darling Ingredients vs. Tyson Foods: Which Stock Stands Out?

DAR and TSN showcase contrasting food industry models as sustainability, protein demand and operational execution shape growth paths.

zacks.com - 2026-05-27 11:46:45

Darling Ingredients: The Recovery Is Visible

Darling Ingredients (DAR) is rated Buy, supported by a visible earnings recovery, improved margins, and a compelling forward valuation versus peers. Q1 2026 delivered sharply higher EBITDA ($406.8M), gross margin expansion to 26.1%, and a return to profitability, signaling the roughest period is likely over. Core Feed and Food Ingredients segments drove margin and EBITDA gains without major volume growth, while DGD's Q1 result was boosted by a non-recurring inventory benefit.

seekingalpha.com - 2026-05-27 11:22:39

Is Darling Ingredients Entering a New Strategic Growth Phase?

DAR shifts focus toward cash flow, operational efficiency and balance-sheet flexibility as renewable fuels conditions improve.

zacks.com - 2026-05-25 12:06:06

Darling Ingredients Benefiting From Rising Health Food Demand Trends?

DAR is benefiting from rising demand for collagen products and expanding its focus on specialty nutrition ingredients.

zacks.com - 2026-05-18 12:10:13

Does Darling (DAR) Have the Potential to Rally 25.15% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in Darling (DAR). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

zacks.com - 2026-05-14 10:55:43

Are Consumer Staples Stocks Lagging Darling Ingredients (DAR) This Year?

Here is how Darling Ingredients (DAR) and Fomento Economico (FMX) have performed compared to their sector so far this year.

zacks.com - 2026-05-14 10:41:35

Earnings Estimates Moving Higher for Darling (DAR): Time to Buy?

Darling Ingredients (DAR) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

zacks.com - 2026-05-13 13:20:30

Darling Ingredients Inc. (DAR) Presents at 21st Annual Global Farm to Market Conference Transcript

Darling Ingredients Inc. (DAR) Presents at 21st Annual Global Farm to Market Conference Transcript

seekingalpha.com - 2026-05-13 11:40:53

Darling Ingredients Up 84.3% in 6 Months: What's Driving the Stock?

DAR stock has surged 84% in six months as renewable diesel margins recover, earnings rebound and operational momentum strengthens.

zacks.com - 2026-05-12 12:05:39

Darling Ingredients Signals Q2 Upside, Renewable Diesel Boost at Investor Day

Darling Ingredients NYSE: DAR used its 2026 Investor Day at the New York Stock Exchange to outline a stronger operating outlook, renewed confidence in its renewable diesel joint venture and a capital allocation plan focused first on debt reduction and then on broader shareholder-return options.

marketbeat.com - 2026-05-11 21:07:27

Darling Ingredients Inc. (DAR) Analyst/Investor Day Transcript

Darling Ingredients Inc. (DAR) Analyst/Investor Day Transcript

seekingalpha.com - 2026-05-11 17:10:43

Darling Ingredients Renewable Diesel Momentum: How Durable Is it?

DAR sees improving momentum as renewable diesel demand, regulatory clarity and stronger fat pricing support key business segments.

zacks.com - 2026-05-11 11:31:13

Darling Ingredients Investors Back All Proposals at Annual Meeting

Darling Ingredients NYSE: DAR stockholders approved all proposals presented at the company's 2026 Annual Meeting of Stockholders, including the election of directors, ratification of the company's auditor, an advisory vote on executive compensation and approval of the 2026 Omnibus Incentive Plan.

marketbeat.com - 2026-05-10 20:05:20

Darling Ingredients Global Feed Demand: Growth Catalyst?

DAR sees feed segment growth fueled by global demand, pricing strength and efficiency gains, boosting margins despite flat volumes.

zacks.com - 2026-05-05 12:20:30

Darling Ingredients Inc. to Highlight Strategic Plan for Profitable Growth at 2026 Investor Day

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) will host its 2026 Investor Day on Monday, May 11, 2026, at 10 a.m. Eastern Time in New York City and via a concurrent webcast. Executive leadership will provide details about the company's strategic priorities and three-year outlook. Darling Ingredients' executives will highlight several key themes, including: Strong foundation: The company's strategic, multi-year investments that have strengthened core assets, enhanced capab.

businesswire.com - 2026-05-04 17:31:00

Darling Ingredients Inc. (DAR) Q1 2026 Earnings Call Transcript

Darling Ingredients Inc. (DAR) Q1 2026 Earnings Call Transcript

seekingalpha.com - 2026-04-30 16:51:39

Darling (DAR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Darling (DAR) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

zacks.com - 2026-04-30 10:30:31

Darling Ingredients (DAR) Q1 Earnings Surpass Estimates

Darling Ingredients (DAR) came out with quarterly earnings of $0.83 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to a loss of $0.16 per share a year ago.

zacks.com - 2026-04-30 08:55:52

Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?

Launched on 11/08/2017, the John Hancock Multifactor Small Cap ETF (JHSC) is a smart beta exchange traded fund offering broad exposure to the Style Box - Small Cap Blend category of the market.

zacks.com - 2026-04-30 07:21:13

Darling Ingredients Inc. Reports First Quarter 2026 Results

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) today reported net income of $134.3 million or $0.83 per diluted share for the first quarter of 2026, compared to a net loss of $(26.2) million, or $(0.16) per diluted share, for the first quarter of 2025. The company also reported total net sales of $1.6 billion for the first quarter of 2026, compared with total net sales of $1.4 billion for the same period a year ago. “This quarter marked a clear inflection point for Darling.

businesswire.com - 2026-04-30 06:34:00

Earnings Preview: BellRing Brands (BRBR) Q2 Earnings Expected to Decline

BellRing Brands (BRBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-28 11:09:24

Darling Ingredients Inc. to Release First Quarter 2026 Financial Results

IRVING, Texas--(BUSINESS WIRE)---- $DAR--Darling Ingredients Inc. (NYSE: DAR) announced today that it will host a conference call on Thursday, April 30, 2026, at 9 a.m. Eastern Time (8 a.m. Central Time) to discuss first quarter 2026 financial results, which will be released earlier that day, and provide an update on company operations. A presentation with accompanying supplemental financial data will also be available at darlingii.com/investors. To access the call as a listener, please register for the.

businesswire.com - 2026-04-16 16:35:00

Darling Ingredients (DAR) Earnings Expected to Grow: Should You Buy?

Darling (DAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

zacks.com - 2026-04-16 11:00:24

What Makes Darling (DAR) a Good Fit for 'Trend Investing'

Darling (DAR) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.

zacks.com - 2026-04-16 09:56:38

Best Momentum Stocks to Buy for April 15th

DAR, ADI and BP made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on April 15th, 2026.

zacks.com - 2026-04-15 11:15:24

New Strong Buy Stocks for April 15th

CALY, BP, ADI, LNNGY and DAR have been added to the Zacks Rank #1 (Strong Buy) List on April 15th, 2026.

zacks.com - 2026-04-15 06:57:07

Best Value Stocks to Buy for April 15th

DAR, BP and PLAB made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 15th, 2026.

zacks.com - 2026-04-15 05:56:04

Get DAR Insider Trade Alerts

DAR Price Target Summary

Last Month

$60.00

2 analysts

Last Quarter

$66.25

4 analysts

Last Year

$59.81

16 analysts

All Time

$64.68

28 analysts

DAR Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2024-10-11 Piper Sandler Maintain Overweight Overweight
2024-10-07 Jefferies Maintain Buy Buy
2024-09-13 TD Cowen Maintain Hold Hold
2024-07-26 Jefferies Maintain Buy Buy
2024-07-12 Scotiabank Maintain Sector Outperform Sector Outperform
2024-06-13 TD Cowen Maintain Hold Hold
2024-06-12 Citigroup Upgrade Neutral Buy
2024-05-20 Stifel Maintain Buy Buy
2024-04-17 JP Morgan Maintain Overweight Overweight
2024-04-11 Scotiabank Maintain Sector Outperform Sector Outperform
2024-04-08 Stifel Maintain Buy Buy
2024-04-03 Citigroup Maintain Neutral Neutral
2024-03-06 Stifel Maintain Buy Buy
2024-02-29 BMO Capital Maintain Outperform Outperform
2024-02-29 Citigroup Maintain Neutral Neutral
2024-01-29 Stifel Maintain Buy Buy
2024-01-26 BMO Capital Maintain Outperform Outperform
2024-01-24 Stephens & Co. Maintain Equal Weight Equal Weight
2023-11-27 Stifel Maintain Buy Buy
2023-11-09 Raymond James Maintain Strong Buy Strong Buy
2023-11-09 BMO Capital Maintain Outperform Outperform
2023-10-24 Raymond James Maintain Strong Buy Strong Buy
2023-10-19 JP Morgan Maintain Overweight Overweight
2023-10-10 Piper Sandler Maintain Overweight Overweight
2023-10-09 Jefferies Maintain Buy Buy
2023-08-22 Stifel Maintain Buy Buy
2023-08-10 JP Morgan Maintain Overweight Overweight
2023-08-10 Stephens & Co. Maintain Equal Weight Equal Weight
2023-08-09 Stephens & Co. Maintain Equal Weight Equal Weight
2023-07-20 JP Morgan Maintain Overweight Overweight
2023-07-13 Piper Sandler Maintain Overweight Overweight
2023-07-13 Stephens & Co. Maintain Equal Weight Equal Weight
2023-06-06 Piper Sandler Maintain Overweight Overweight
2023-05-15 UBS Maintain Buy Buy
2023-05-15 Jefferies Maintain Buy Buy
2023-05-11 Stephens & Co. Maintain Equal Weight Equal Weight
2023-05-11 BMO Capital Maintain Outperform Outperform
2023-04-24 Stifel Maintain Buy Buy
2023-04-14 Stifel Maintain Buy Buy
2023-04-13 Baird Maintain Outperform Outperform
2023-04-11 JP Morgan Maintain Overweight Overweight
2023-03-01 Raymond James Maintain Strong Buy Strong Buy
2023-02-28 Stephens & Co. Maintain Equal Weight Equal Weight
2023-02-06 Baird Maintain Outperform Outperform
2023-01-30 Stifel Maintain Buy Buy
2023-01-20 Raymond James Maintain Strong Buy Strong Buy
2023-01-20 Stifel Maintain Buy Buy
2023-01-17 Stephens & Co. Downgrade Overweight Equal Weight
2022-12-19 Piper Sandler Maintain Overweight Overweight
2022-12-14 UBS Maintain Buy Buy
2022-10-19 Jefferies Maintain Buy Buy
2022-09-12 Stifel Maintain Buy Buy
2022-09-08 Scotiabank Maintain Sector Outperform Outperform
2022-08-24 Piper Sandler Maintain Overweight Overweight
2022-08-11 Raymond James Maintain Strong Buy Strong Buy
2022-07-15 Raymond James Maintain Strong Buy Strong Buy
2022-04-25 Cowen & Co. Maintain Market Perform Perform
2022-04-20 Stephens & Co. Maintain Overweight Overweight
2022-03-14 Credit Suisse Maintain Outperform Outperform
2022-03-02 Raymond James Maintain Strong Buy Strong Buy
2022-03-02 Stephens & Co. Maintain Overweight Overweight
2022-02-17 Raymond James Maintain Strong Buy Strong Buy
2021-11-11 Stephens & Co. Maintain Overweight Overweight
2021-08-16 Raymond James Maintain Strong Buy Strong Buy
2021-08-12 Credit Suisse Maintain Outperform Outperform
2021-08-12 Stephens & Co. Maintain Overweight Overweight
2021-08-12 Baird Maintain Outperform Outperform
2021-07-16 Raymond James Downgrade Strong Buy Buy
2021-07-15 Evercore ISI Group Maintain Outperform Outperform
2021-06-25 BMO Capital Upgrade Market Perform Outperform
2021-06-18 Piper Sandler Maintain Overweight Overweight
2021-06-09 Citigroup Maintain Buy Buy
2021-05-13 Baird Maintain Outperform Outperform
2021-05-13 BMO Capital Maintain Market Perform Market Perform
2021-03-05 JP Morgan Upgrade Neutral Overweight
2021-03-04 Credit Suisse Maintain Outperform Outperform
2021-03-02 Piper Sandler Maintain Overweight Overweight
2020-11-25 Roth Capital Maintain Buy Buy
2020-11-05 BMO Capital Maintain Market Perform Market Perform
2020-10-22 Roth Capital Maintain Buy Buy
2020-10-09 Tudor Pickering Maintain Buy Buy
2020-09-28 Credit Suisse Maintain Outperform Outperform
2020-07-16 Berenberg Maintain Buy Buy
2020-05-08 JP Morgan Maintain Neutral Neutral
2020-03-09 Goldman Sachs Upgrade Neutral Buy
2020-01-15 JP Morgan Downgrade Overweight Neutral
2020-01-14 Baird Maintain Outperform Outperform
2018-11-19 JP Morgan Upgrade Neutral Overweight
2018-08-10 JP Morgan Maintain Neutral Neutral
2018-08-10 BMO Capital Maintain Market Perform Market Perform
2018-03-01 Goldman Sachs Downgrade Buy Neutral
2017-11-06 Canaccord Genuity Maintain Buy Buy
2017-10-06 JP Morgan Downgrade Overweight Neutral
2017-08-11 Baird Maintain Outperform Outperform
2017-03-23 Baird Maintain Outperform Outperform
2016-08-15 JP Morgan Maintain Overweight Overweight
2016-06-29 Goldman Sachs Upgrade Neutral Buy
2016-05-26 JP Morgan Upgrade Neutral Overweight
2016-04-01 Avondale Partners Maintain Market Outperform Market Outperform
2016-03-03 JP Morgan Maintain Neutral Neutral
2015-11-11 Canaccord Genuity Maintain Buy Buy
2015-10-28 JP Morgan Maintain Neutral Neutral
2015-07-14 BB&T Capital Maintain Buy Buy
2015-07-13 BB&T Capital Maintain Buy Buy
2015-05-21 Roth Capital Maintain Buy Buy
2015-05-12 Canaccord Genuity Maintain Buy Buy
2015-03-06 Goldman Sachs Downgrade Buy Neutral
2015-01-05 Off Wall Street Maintain Long Term Buy Buy
2013-12-17 Avondale Partners Upgrade Market Perform Market Outperform
2013-11-18 Wedbush Downgrade Outperform Market Perform
2013-08-26 Canaccord Genuity Upgrade Hold Buy
2013-06-20 Wedbush Maintain Outperform Outperform
2013-05-13 BMO Capital Maintain Market Perform Market Perform
2013-05-08 Maxim Group Upgrade Hold Buy
2012-12-21 Stephens & Co. Downgrade Overweight Equal Weight
2012-11-12 BMO Capital Maintain Market Perform Market Perform
2012-11-07 Maxim Group Downgrade Buy Hold
2012-11-05 Avondale Partners Downgrade Market Outperform Market Perform
2012-05-11 Stephens & Co. Upgrade Equal Weight Overweight